The 13-year long-term follow-up on the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in Chinese females vaccinated at 20-45 years of age.

ABSTRACT:

Trial registration

The LTFU study was registered at the Chinese Clinical Trial Registry, ChiCTR2100052313.

SUBMITTER: Wen T 

PROVIDER: S-EPMC11486006 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature